Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes

August 2008

Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes?

We know that lowering A1c decreases the risk of microvascular disease such as retinopathy and nephropathy.

So many experts hoped it would also improve MACROvascular outcomes such as heart attacks and strokes.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes
Infectious Diseases tendon injuries will be in a new black box warning for all oral and IV quinolones (ciprofloxacin, etc)
Dyslipidemia whether more CHILDREN should be treated for dyslipidemia
Antithrombotics what to do about aspirin, clopidogrel, NSAIDs, and warfarin when patients need surgery
Antithrombotics two new ORAL anticoagulants called Xarelto (rivaroxaban) and Pradaxa (dabigatran)
Men's Health Avodart (dutasteride) with Flomax (tamsulosin) for benign prostatic hyperplasia (BPH)
Men's Health finasteride (Proscar) to PREVENT prostate cancer
Aspirin whether they should take TWO aspirin daily
Pediatrics Many infants get antireflux meds when they don't need them
Respiratory & Allergy when to use a spacer with a metered-dose inhaler (MDI)
Supplements There's confusion about the different oral iron products
Sports Medicine drugs athletes are using to enhance performance